About
Vaccines
Areas of Focus
Categories
VaccineAustralia
Team (45)
Antiksha Joshi
Director of Quality
GPN Vaccines
team_member
Barry Palte, FIA
Non-Executive Director
GPN Vaccines
team_member
Brooke Dilmetz, PhD
Technical Operations Manager
GPN Vaccines
team_member
Bruce Forrest
Executive Chief Scientific Officer
GPN Vaccines
executive
Cameron Smith
Research Assistant
GPN Vaccines
team_member
Carla Gallasch
PhD Student
GPN Vaccines
team_member
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
295
By Phase
PHASE1: 3PHASE1/PHASE2: 1
By Status
COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07205289Lead Sponsor
Serum Collection Study for Assay Development
PHASE1Recruiting
12 participants
Started: Oct 31, 2025 · Completed: Jun 30, 2026
NCT06562790Lead Sponsor
Study of Gamma PN3 in the Elderly
PHASE1Completed
105 participants
Started: Aug 26, 2024 · Completed: Mar 31, 2025
NCT05982314Lead Sponsor
Extension Safety and Immunogenicity Study of GPNV-001
PHASE1/PHASE2Completed
60 participants
Started: Jul 17, 2023 · Completed: Aug 30, 2024
NCT05667740Lead Sponsor
Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.
PHASE1Completed
118 participants
Started: Jan 16, 2023 · Completed: Oct 8, 2023
Locations (1)
Headquarters
Canberra, Australia
Map
Loading map...